Boosted immunity to the common cold might protect children from COVID-19.

Lavinder, Jason J; Ippolito, Gregory C

Lavinder, Jason J; Ippolito, Gregory C.

Lavinder JJ; Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
Ippolito GC; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA. gci@utexas.edu.

Nat Immunol ; 23(1): 8-10, 2022 01.

Article in English | MEDLINE | ID: covidwho-1585823

Subject(s)

Antibodies, Viral/blood; COVID-19/prevention & control; Common Cold/immunology; SARS-CoV-2/immunology; T-Lymphocytes/immunology; Adolescent; Adult; Age Factors; COVID-19/pathology; Child; Child, Preschool; Humans; Infant; Lymphocyte Count; Risk Factors; Spike Glycoprotein, Coronavirus/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: T-Lymphocytes / Common Cold / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Prognostic study Limits: Adolescent / Adult / Child / Child, preschool / Humans / Infant Language: English Journal: Nat Immunol Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: S41590-021-01094-x

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google